BL-M11D1

· Sichuan Baili Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BL-M11D1, covering 2025-09-26 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia [Phase 2, Phase 3]

See pricing